Alphavirus antiviral drug development: Scientific gap analysis and prospective research areas

Erin Reichert, Amanda Clase, Ada Bacetty, Joseph Larsen

Research output: Contribution to journalArticlepeer-review

45 Scopus citations


The New World alphaviruses Venezuelan equine encephalitis virus (VEEV), eastern equine encephalitis virus (EEEV), and western equine encephalitis virus (WEEV) pose a significant threat to human health as the etiological agents of serious viral encephalitis through natural infection as well as through their potential use as a biological weapon. At present, there is no FDA-approved medical treatment for infection with these viruses. The Defense Threat Reduction Agency, Joint Science and Technology Office for Chemical and Biological Defense (DTRA/JSTO), is currently funding research aimed at developing antiviral drugs and vaccines against VEEV, EEEV, and WEEV. A review of antiviral drug discovery efforts for these viruses revealed significant gaps in the data, assays, and models required for successful drug development. This review provides a description of these gaps and highlights specific critical research areas for the development of a target-based drug discovery program for the VEEV, EEEV, and WEEV nonstructural proteins. These efforts will increase the probability of the successful development of a pharmaceutical intervention against these viral threat agents. 2009

Original languageEnglish (US)
Pages (from-to)413-427
Number of pages15
JournalBiosecurity and Bioterrorism
Issue number4
StatePublished - Dec 1 2009

All Science Journal Classification (ASJC) codes

  • Health(social science)
  • Public Health, Environmental and Occupational Health
  • Management, Monitoring, Policy and Law


Dive into the research topics of 'Alphavirus antiviral drug development: Scientific gap analysis and prospective research areas'. Together they form a unique fingerprint.

Cite this